Growth Metrics

Angiodynamics (ANGO) Cash from Operations (2016 - 2026)

Angiodynamics' Cash from Operations history spans 17 years, with the latest figure at 3110000.0 for Q1 2026.

  • For Q1 2026, Cash from Operations rose 76.37% year-over-year to 3110000.0; the TTM value through Feb 2026 reached 4448000.0, up 118.58%, while the annual FY2025 figure was 10128000.0, 64.03% up from the prior year.
  • Cash from Operations reached 3110000.0 in Q1 2026 per ANGO's latest filing, down from 4661000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 18811000.0 in Q2 2025 to a low of 25899000.0 in Q3 2023.
  • Average Cash from Operations over 5 years is 3106000.0, with a median of 1370000.0 recorded in 2023.
  • Peak YoY movement for Cash from Operations: soared 286.35% in 2022, then plummeted 1014.31% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 7499000.0 in 2022, then decreased by 29.78% to 5266000.0 in 2023, then plummeted by 53.04% to 2473000.0 in 2024, then skyrocketed by 88.48% to 4661000.0 in 2025, then crashed by 166.72% to 3110000.0 in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Cash from Operations are 3110000.0 (Q1 2026), 4661000.0 (Q4 2025), and 15914000.0 (Q3 2025).